Log in to save to my catalogue
Log in to save to my catalogue

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of t...

| Ask | Become a Library member

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A579742241

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux

About this item

Full title

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux

Author / Creator

Torres-Adorno, Angie M , Vitrac, Heidi , Qi, Yuan , Tan, Lin , Levental, Kandice R , Fan, Yang-Yi and Yang, Peiying

Publisher

Nature Publishing Group

Journal title

Oncogene, 2019, Vol.38 (12), p.2135

Language

English

Formats

Reports

Publication information

Publisher

Nature Publishing Group

Subjects

More information

Alternative Titles

Full title

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A579742241

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A579742241

Other Identifiers

ISSN

0950-9232

DOI

10.1038/s41388-018-0569-5

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections